These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 32051830)
21. Angiographic evaluation of hepatic arterial injury after cisplatin and Gelfoam-based transcatheter arterial chemoembolization for hepatocellular carcinoma in a 205 patient cohort during a 6-year follow-up. Suh CH; Shin JH; Yoon HM; Yoon HK; Ko GY; Gwon DI; Kim JH; Sung KB Br J Radiol; 2014 Sep; 87(1041):20140054. PubMed ID: 24970695 [TBL] [Abstract][Full Text] [Related]
22. Hemodynamic Changes on Cone-Beam Computed Tomography during Balloon-Occluded Transcatheter Arterial Chemoembolization Using Miriplatin for Hepatocellular Carcinoma: A Preliminary Study. Ishikawa T; Imai M; Owaki T; Sato H; Nozawa Y; Sano T; Iwanaga A; Seki K; Honma T; Yoshida T; Kudo M Dig Dis; 2017; 35(6):598-601. PubMed ID: 29040993 [TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation. Bargellini I; Vignali C; Cioni R; Petruzzi P; Cicorelli A; Campani D; De Simone P; Filipponi F; Bartolozzi C Radiology; 2010 Apr; 255(1):289-300. PubMed ID: 20308465 [TBL] [Abstract][Full Text] [Related]
24. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization. Miyayama S; Matsui O; Taki K; Minami T; Ryu Y; Ito C; Nakamura K; Inoue D; Notsumata K; Toya D; Tanaka N; Mitsui T Cardiovasc Intervent Radiol; 2006; 29(1):39-48. PubMed ID: 16328697 [TBL] [Abstract][Full Text] [Related]
25. Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma. Hatanaka T; Arai H; Kakizaki S World J Hepatol; 2018 Jul; 10(7):485-495. PubMed ID: 30079135 [TBL] [Abstract][Full Text] [Related]
26. Initial Experience with Balloon-Occluded Trans-catheter Arterial Chemoembolization (B-TACE) for Hepatocellular Carcinoma. Maruyama M; Yoshizako T; Nakamura T; Nakamura M; Yoshida R; Kitagaki H Cardiovasc Intervent Radiol; 2016 Mar; 39(3):359-66. PubMed ID: 26711804 [TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles. Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419 [TBL] [Abstract][Full Text] [Related]
28. Computed tomographic perfusion with 160-mm coverage: comparative analysis of hepatocellular carcinoma treated by two transarterial chemoembolization courses relative to magnetic resonance imaging findings. Bayle M; Clerc-Urmès I; Ayav A; Bronowicki JP; Petit I; Orry X; Laurent V Abdom Radiol (NY); 2019 Jan; 44(1):85-94. PubMed ID: 30054686 [TBL] [Abstract][Full Text] [Related]
29. Balloon-Assisted Chemoembolization Using a Micro-Balloon Catheter Alongside a Microcatheter for a Hepatocellular Carcinoma with a Prominent Arterioportal Shunt: A Case Report. Hoshiai S; Mori K; Ishiguro T; Konishi T; Uchikawa Y; Fukuda K; Minami M Cardiovasc Intervent Radiol; 2017 Apr; 40(4):625-628. PubMed ID: 27987001 [TBL] [Abstract][Full Text] [Related]
30. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm. Yan JY; Zhang JL; Wang MQ; Yuan K; Bai YH; Wang Y; Xin HN; Wang ZJ; Liu FY; Duan F; Fu JX Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma. Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945 [TBL] [Abstract][Full Text] [Related]
33. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis. Hu J; Bao Q; Cao G; Zhu X; Yang R; Ji X; Xu L; Zheng K; Li W; Xing B; Wang X Cardiovasc Intervent Radiol; 2020 Jul; 43(7):996-1005. PubMed ID: 31974744 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the role of cisplatin-conjugated-soluble gelatin sponge: feasibility study in a swine model. Ikoma A; Kawai N; Sato M; Minamiguchi H; Nakata K; Nakai M; Sanda H; Sonomura T; Kanayama Y; Sakai Y Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1097-104. PubMed ID: 23073562 [TBL] [Abstract][Full Text] [Related]
35. Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma. Imai N; Ikeda K; Seko Y; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H Oncology; 2011; 80(3-4):188-94. PubMed ID: 21709428 [TBL] [Abstract][Full Text] [Related]
36. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis. Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514 [No Abstract] [Full Text] [Related]
37. Retrospective European Multicentric Evaluation of Selective Transarterial Chemoembolisation with and without Balloon-Occlusion in Patients with Hepatocellular Carcinoma: A Propensity Score Matched Analysis. Golfieri R; Bezzi M; Verset G; Fucilli F; Mosconi C; Cappelli A; Paccapelo A; Lucatelli P; Magand N; Rode A; De Baere T Cardiovasc Intervent Radiol; 2021 Jul; 44(7):1048-1059. PubMed ID: 33709273 [TBL] [Abstract][Full Text] [Related]
38. [Is Balloon-Occluded Transcatheter Arterial Chemoembolization Effective in Patients with Hepatocellular Carcinoma That Is Unresponsive to Conventional Transcatheter Arterial Chemoembolization ?]. Hatanaka T; Arai H; Shibasaki M; Tojima H; Takizawa D; Toyoda M; Takayama H; Abe T; Sato K; Kakizaki S Gan To Kagaku Ryoho; 2018 Sep; 45(9):1291-1296. PubMed ID: 30237370 [TBL] [Abstract][Full Text] [Related]
39. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics. Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269 [TBL] [Abstract][Full Text] [Related]